FDA Inspection 1310508 — HCSC Blood Center

HCSC Blood Center — FEI 2577633

The FDA completed an inspection of HCSC Blood Center on March 23, 2026 in Reading, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 23, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Reading, PA (United States)